OpenURL Connection Search

Select item for more details and to access through your institution.

Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL.
Published in:
2009
By:
- Mussolin, L.;
- Bonvini, P.;
- Ait-Tahar, K.;
- Pillon, M.;
- Tridello, G.;
- Buffardi, S.;
- Lombardi, A.;
- Pulford, K.;
- Rosolen, A.
Publication type:
Letter
Primary mediastinal large B-cell lymphoma: Outcome of a series of pediatric patients treated with high-dose methotrexate and cytarabine plus anti-CD20.
Published in:
2018
By:
- Pillon, Marta;
- Carraro, E.;
- Mussolin, L.;
- Conter, V.;
- Tondo, A.;
- Aricò, M.;
- Mura, R.;
- Sala, A.;
- Vinti, L.;
- Buffardi, S.;
- Pierani, P.;
- d'Amore, E. S. G.;
- Basso, G.
Publication type:
journal article
RESPONSE‐ADAPTED TREATMENT WITH NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN YOUNG PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: CHECKMATE 744 SUBGROUP ANALYSES.
Published in:
Hematological Oncology, 2019, v. 37, p. 56, doi. 10.1002/hon.26_2629
By:
- Kelly, K.M.;
- Daw, S.;
- Mauz‐Körholz, C.;
- Mascarin, M.;
- Michel, G.;
- Cooper, S.;
- Beishuizen, A.;
- Leger, K.J.;
- Garaventa, A.;
- Buffardi, S.;
- Brugières, L.;
- Harker‐Murray, P.;
- Cole, P.D.;
- Drachtman, R.A.;
- Manley, T.;
- Francis, S.;
- Sacchi, M.;
- Leblanc, T.
Publication type:
Article
RESPONSE‐ADAPTED TREATMENT WITH NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN YOUNG PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: CHECKMATE 744 SUBGROUP ANALYSES.
Published in:
Hematological Oncology, 2019, v. 37, p. 56, doi. 10.1002/hon.26_2629
By:
- Kelly, K.M.;
- Daw, S.;
- Mauz‐Körholz, C.;
- Mascarin, M.;
- Michel, G.;
- Cooper, S.;
- Beishuizen, A.;
- Leger, K.J.;
- Garaventa, A.;
- Buffardi, S.;
- Brugières, L.;
- Harker‐Murray, P.;
- Cole, P.D.;
- Drachtman, R.A.;
- Manley, T.;
- Francis, S.;
- Sacchi, M.;
- Leblanc, T.
Publication type:
Article

Found: 4

Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL.

Primary mediastinal large B-cell lymphoma: Outcome of a series of pediatric patients treated with high-dose methotrexate and cytarabine plus anti-CD20.

RESPONSE‐ADAPTED TREATMENT WITH NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN YOUNG PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: CHECKMATE 744 SUBGROUP ANALYSES.

RESPONSE‐ADAPTED TREATMENT WITH NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN YOUNG PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: CHECKMATE 744 SUBGROUP ANALYSES.